Related Experiment Video
Updated: Jul 4, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Folate fortification and supplementation--are we there yet?
Benjamin Bar-Oz1, Gideon Koren, Patricia Nguyen
1Department of Neonatology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel.
Many women of child-bearing age in Ontario have low red blood cell (RBC) folate levels, increasing the risk of neural tube defects (NTDs). Fortification strategies need enhancement to ensure adequate folate protection.
Area of Science:
- Public Health
- Nutritional Science
- Obstetrics
Background:
- Folic acid fortification of flour has reduced neural tube defects (NTDs).
- Assessing red blood cell (RBC) folate levels in women of child-bearing age is crucial for NTD prevention.
- Ontario's fortification program effectiveness requires ongoing evaluation.
Purpose of the Study:
- To determine if women of child-bearing age in Ontario have adequate RBC folate levels for NTD prevention.
- To evaluate the impact of folic acid fortification on folate status in the target population.
Main Methods:
- Retrospective review of laboratory data on RBC folic acid levels.
- Analysis included demographic and clinical data (age, gender, hemoglobin, MCV, pregnancy test).
- Focus on non-anemic, normocytic females aged 14-45; NTD protection defined as RBC folate >900 nmol/L.
Main Results:
- In 2006, 40% of women of child-bearing age had RBC folate below 900 nmol/L.
- 36% of pregnant women in the study period had suboptimal RBC folate levels (<900 nmol/L).
- A significant proportion of women remained sub-optimally protected against NTDs.
Conclusions:
- A substantial percentage of pregnant women in Ontario are at risk for NTDs due to inadequate folate levels.
- Recommendations include increasing mandatory folic acid concentrations in flour.
- Public education and enhanced folic acid content in prenatal supplements are also advised.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Vitamins
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Cancer Prevention
Some...
